Table 4.
Intervention Effects of the Secondary Outcomes at the Different Measurement Occasions
| Over time | After intervention | 6-mo follow-up | 12-mo follow-up | |||||
| Mean (95% CI) | p Value | Mean (95% CI) | p Value | Mean (95% CI) | p Value | Mean (95% CI) | p Value | |
| Steps | 242 (−585 to 1,069) | 0.564 | 729 (−330 to 1,789) | 0.176 | −429 (−1,528 to 670) | 0.442 | 339 (−737 to 1,416) | 0.534 |
| Time spent in MVPA | −1.4 (−38.6 to 35.8) | 0.940 | 11.3 (−44.6 to 67.2) | 0.689 | −11.3 (−66.2 to 43.6) | 0.684 | 7.6 (−49.7 to 65.0) | 0.792 |
| SF-36: physical component score | 1.1 (−1.7 to 3.8) | 0.439 | 0.7 (−2.7 to 4.1) | 0.702 | 1.5 (−1.9 to 5.0) | 0.379 | 1.0 (−2.5 to 4.5) | 0.586 |
| SF-36: mental component score | 0.1 (−1.1 to 1.2) | 0.910 | 0.4 (−1.1 to 1.9) | 0.586 | 0.0 (−1.6 to 1.5) | 0.969 | −0.2 (−1.7 to 1.4) | 0.818 |
| ACTIVLIM | 0.1 (−0.3 to 0.5) | 0.506 | 0.0 (−0.4 to 0.4) | 0.950 | 0.3 (−0.1 to 0.7) | 0.176 | 0.1 (−0.3 to 0.5) | 0.639 |
| Self-efficacy scale | 0.5 (−0.8 to 1.7) | 0.454 | 0.3 (−1.2 to 1.9) | 0.670 | 0.4 (−1.2 to 1.9) | 0.616 | 0.7 (−0.8 to 2.3) | 0.357 |
| MVT musculus quadriceps strongest leg | −0.3 (−6.6 to 6.1) | 0.932 | −1.4 (−9.2 to 6.4) | 0.724 | 1.1 (−7.1 to 9.3) | 0.792 | 0.1 (−8.2 to 8.4) | 0.988 |
| MVT musculus triceps surae strongest leg | −0.8 (−5.9 to 4.3) | 0.760 | −0.9 (−7.6 to 5.8) | 0.784 | 0.9 (−6.3 to 8.2) | 0.797 | −1.9 (−9.3 to 5.4) | 0.602 |
| Cholesterol | −0.1 (−0.4 to 0.2) | 0.502 | −0.2 (−0.5 to 0.2) | 0.265 | 0.0 (−0.3 to 0.4) | 0.880 | −0.1 (−0.5 to 0.3) | 0.558 |
| HDL | 0.0 (−0.1 to 0.0) | 0.321 | 0.0 (−0.1 to 0.1) | 0.843 | 0.0 (−0.1 to 0.1) | 0.510 | −0.1 (−0.2 to 0.0) | 0.085 |
| LDL | −0.1 (−0.4 to 0.1) | 0.298 | −0.2 (−0.6 to 0.1) | 0.139 | −0.1 (−0.4 to 0.3) | 0.728 | −0.1 (−0.4 to 0.2) | 0.545 |
| VLDL | 0.0 (−0.2 to 0.2) | 0.873 | 0.0 (−0.3 to 0.2) | 0.777 | 0.1 (−0.2 to 0.4) | 0.451 | 0.0 (−0.3 to 0.3) | 0.991 |
| Triglycerides | 0.1 (0.0 to 0.3) | 0.094 | 0.1 (−0.1 to 0.2) | 0.559 | 0.2 (0.0 to 0.4) | 0.049 | 0.1 (0.0 to 0.3) | 0.152 |
| Glucose | −0.1 (−0.2 to 0.0) | 0.186 | 0.0 (−0.2 to 0.1) | 0.576 | 0.0 (−0.2 to 0.2) | 0.752 | −0.2 (−0.4 to −0.1) | 0.008 |
| Waist circumference | 1.3 (−1.0 to 3.6) | 0.258 | 2.4 (0.1 to 4.7) | 0.042 | 1.5 (−0.7 to 3.8) | 0.177 | 1.3 (−1.0 to 3.6) | 0.258 |
| Creatine kinase | −0.7 (−52.0 to 50.6) | 0.978 | 46.3 (−39.0 to 131.5) | 0.286 | −5.6 (−95.8 to 84.5) | 0.902 | −49.4 (−140.3 to 41.5) | 0.285 |
| Blood pressure: diastolic | 1.0 (−2.5 to 4.4) | 0.571 | 1.3 (−2.8 to 5.5) | 0.521 | 0.8 (−3.6 to 5.1) | 0.725 | 0.6 (−3.8 to 5.0) | 0.774 |
| Blood pressure: systolic | −0.6 (−5.6 to 4.4) | 0.814 | 0.4 (−5.9 to 6.8) | 0.892 | −2.7 (−9.5 to 4.0) | 0.425 | 0.7 (−6.2 to 7.5) | 0.848 |
| WECT: distance | 5.1 (−7.3 to 17.5) | 0.411 | 1.5 (−12.9 to 15.8) | 0.840 | 10.8 (−4.1 to 25.8) | 0.153 | 3.9 (−11.2 to 19.0) | 0.611 |
| WECT: steady state | 0.9 (0.0 to 1.8) | 0.041 | 1.1 (−0.0 to 2.2) | 0.053 | 0.8 (−0.3 to 1.9) | 0.173 | 0.9 (−0.3 to 2.0) | 0.145 |
Abbreviations: HDL = high-density lipoprotein; LDL = low-density lipoprotein; MVPA = moderate-to-vigorous physical activity; MVT = maximal voluntary torque; SF-36 = Short Form 36-Item; VLDL = very low–density lipoprotein; WECT = walking energy consumption test.